HOSPICES CIVILS DE LYON
🇫🇷France
Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal Networks
- Conditions
- Post Partum Haemorrhage
- First Posted Date
- 2006-06-27
- Last Posted Date
- 2007-04-27
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 6500
- Registration Number
- NCT00344929
- Locations
- 🇫🇷
Cyrille Colin, Lyon, France
Consequences of Parenteral Nutrition Photoprotection on Oxidant Related Diseases Among Extremely Low Birth Weight Infants
Not Applicable
Completed
- Conditions
- Infant, Premature
- Interventions
- Device: photoprotected bags, tubing, syringesDevice: standard tubing and bags
- First Posted Date
- 2006-05-22
- Last Posted Date
- 2019-05-28
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 591
- Registration Number
- NCT00328419
- Locations
- 🇫🇷
Angelique Denis, Lyon, France
Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases
Phase 4
Terminated
- Conditions
- Colorectal CancerNeoplasm Metastasis
- Interventions
- First Posted Date
- 2006-05-18
- Last Posted Date
- 2009-02-09
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 31
- Registration Number
- NCT00327093
- Locations
- 🇫🇷
Jean-Alain Chayvialle, Lyon, France
Effects of Nurse-counselling in the Improvement of the type1 Diabetes Control in Adolescents
Not Applicable
Completed
- Conditions
- Type 1 Diabetes
- Interventions
- Behavioral: nurse-counselling
- First Posted Date
- 2006-03-29
- Last Posted Date
- 2011-12-30
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 77
- Registration Number
- NCT00308256
- Locations
- 🇫🇷
Marc Nicolino, Lyon, France
IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer
Phase 3
Completed
- Conditions
- Stage IV Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2006-03-09
- Last Posted Date
- 2019-05-28
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 842
- Registration Number
- NCT00300586
- Locations
- 🇫🇷
Maurice PEROL, Lyon, France
Oral Tolerance in Cow's Milk Allergy in the Infant
- Conditions
- Cow's Milk Allergy
- First Posted Date
- 2006-03-02
- Last Posted Date
- 2007-04-27
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 50
- Registration Number
- NCT00298376
- Locations
- 🇫🇷
Alain Lachaux, Lyon, France
NEPHRODIAB2 Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin Levels
Not Applicable
- Conditions
- Chronic Kidney Disease
- First Posted Date
- 2006-01-19
- Last Posted Date
- 2007-10-04
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 204
- Registration Number
- NCT00279084
- Locations
- 🇫🇷
Joëlle Gillet, Lyon, France
Tongue Pressure Recording During Speech
- Conditions
- Complete Toothless
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2007-04-27
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 20
- Registration Number
- NCT00273078
- Locations
- 🇫🇷
Brigitte GROGOGEAT, Lyon, France
RESTIT : Evaluation of Resorbable Osteosynthesis Devices Versus Titanium in Maxillofacial Surgery
Not Applicable
- Conditions
- Maxillo-Facial Surgery
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2007-04-27
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 308
- Registration Number
- NCT00240669
- Locations
- 🇫🇷
Pierre Bouletreau, Lyon, France
Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)
Phase 2
Completed
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Drug: Cisplatin-GemzarDrug: Cisplatin-Navelbine-RadiotherapyDrug: Carboplatin-Taxol-Radiotherapy
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2019-05-28
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 120
- Registration Number
- NCT00198367
- Locations
- 🇫🇷
Centre Hospitalier Lyon-Sud - Radiotherapie/Oncologie, Pierre-Benite, France
© Copyright 2025. All Rights Reserved by MedPath